Dynacare is committed to aligning test offerings with the most accurate and up-to date services to support timely, cost-effective, and quality patient care. In the area of hereditary cancer screening, Dynacare is transitioning to the Invitae® Multi-Cancer Panel, which covers 70 genes compared to the current Color 30-gene panel. Invitae recently joined the Labcorp family, expanding genetic testing solutions offered through Labcorp and Dynacare. Given the superior coverage of the Invitae® test, Dynacare will discontinue the Color® Test effective October 31st, 2024.
Read More: Change to Hereditary Cancer Screening Service